2009甲型 H1 N1流感诊治现状(2)
研究者正在从多个角度对此次流感的世界性大流行进行深入的研究和评估[20]。疫苗接种是人群防控的重要措施，虽然目前各国已完成疫苗的早期研究，但对远期的安全性及疗效有待进一步研究。
参考文献
[1] Outbreak news.Swine influenza[J].Wkly Epidemio Rec，2009，84(18)：149—153
[2] Zarocostas J. World Health Organization declaresA (H1 N1) influenza pandemic [J].B MJ，2009，338：b2425
[3] Centers for Disease Control andPrevention (CDC).Swine influenza A (H1N1) infection in twochildren - Southern California，March –April 2009[J].MMWRMorb Mortal Wkly Rep，2009，58(15)：400 -402
, http://www.100md.com
[4] DowdASwine fluclaimsfirst European death.as cases worldwide rise to 36，000[J].BMJ，2009，338：b2470
[5] Househoid Transmission of 2009 Pandemic Influenza A (H1N1) Vivus in the United States,N Eng J Med 2009;361:2619-27.Ddcember 31,2009
[6] Outbeak of 2009 Pandemic Influenza A(H1N1) at a New York City School,N Eng J Med 2009;361:2628-36.Ddcember 31,2009
[7] Novel Swine -Origin Influenza A (H1N1) Virus Investiga tion Team，DawoodFS，Jain S，eta1 . Emergenceofanovel swine- origininfluen z aA(H1N1) virusinhumans [J].NEnglJMed，2009，360(25)：2605-2615
, 百拇医药
[8] Clinical Features of the Initial Cases of 2009 Pandemic Influenza A(H1N1) Vivus Infeection in China,N Eng J Med 2009;361:2507-17.Ddcember 24,2009.)
[9] Baden LR，Drazen JM，Kritek PA，eta1. H1N1 influenzaA disease-information for healthprofessionals [J].NEnglJMed，2009，360(25)：2666 -2667
[10] CDC,USA.H1N1 Flu (Swine Flu)[EB/OL].(2009-07- 24).http：//edc.gov/h1n1Ⅱu/index.htm
[11] Centers for Disease Control and Prevention (CDC).Serumcross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine [J]. MMWR MorbMortal WklyRep：2009，58(19)：521-524
, 百拇医药
[12] Enserink M Kaiser J.Swine flu outbreak.Devilishdilemmassurround pandemic flu vaccine [J].Science，2009，324(5928)：702—705
[13] VellozziC，Burwen D R，DobardzicA，eta1.Safetyof trivalent inactivatedinfluenza vaccinesin adults：background for pandemic influenza vaccine safety monitoring [J] Vaccine，2009，27(15)：2114- 2120
[14] Response after One Dose of a Monovalent Influenza A(H1N1) Vaccine—Preliminary Report,N Eng J Med 2009;361:2407-17
, 百拇医药
[15] Trial of Influenza A(H1N1)2009 Monovalent MF59-Adjuvanted Vaccine- Preliminary Report,N Eng J Med 2009;361:2303-12
[16] Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus,N Eng J Med 2009;361:2602-07
[17] Feng-Cai Zhu.A Novel Influenza A (H1N1) Vaccine in Various Age Groups.NEnglJ Med2009; 361:2414-23
[18] Tristan W.Clark,M.R.C.P.,Manish Pareek,M.R.C.P.,Katja Hoschler,Ph.D.,etal.Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine,N Engl J Med 2009;361:2424-35
, 百拇医药
[19] Centers for DiseaseControl and Prevention (CDC).Update：drug susceptibility of swine-origininfuenza A(H1N1) viruses，April 2009 [J].M MWR Morb Mortal Wkly Rep，2009，5 8(16)：433—435
[20] Neumann G，Noda T，Kawaoka Y.Emergence and pandemic potential of swine-origin H1N1 influenza virus [J]. ature，2009，459(7249)：931-939
共2页, 百拇医药(龙胜泽 秦志强)
参考文献
[1] Outbreak news.Swine influenza[J].Wkly Epidemio Rec，2009，84(18)：149—153
[2] Zarocostas J. World Health Organization declaresA (H1 N1) influenza pandemic [J].B MJ，2009，338：b2425
[3] Centers for Disease Control andPrevention (CDC).Swine influenza A (H1N1) infection in twochildren - Southern California，March –April 2009[J].MMWRMorb Mortal Wkly Rep，2009，58(15)：400 -402
, http://www.100md.com
[4] DowdASwine fluclaimsfirst European death.as cases worldwide rise to 36，000[J].BMJ，2009，338：b2470
[5] Househoid Transmission of 2009 Pandemic Influenza A (H1N1) Vivus in the United States,N Eng J Med 2009;361:2619-27.Ddcember 31,2009
[6] Outbeak of 2009 Pandemic Influenza A(H1N1) at a New York City School,N Eng J Med 2009;361:2628-36.Ddcember 31,2009
[7] Novel Swine -Origin Influenza A (H1N1) Virus Investiga tion Team，DawoodFS，Jain S，eta1 . Emergenceofanovel swine- origininfluen z aA(H1N1) virusinhumans [J].NEnglJMed，2009，360(25)：2605-2615
, 百拇医药
[8] Clinical Features of the Initial Cases of 2009 Pandemic Influenza A(H1N1) Vivus Infeection in China,N Eng J Med 2009;361:2507-17.Ddcember 24,2009.)
[9] Baden LR，Drazen JM，Kritek PA，eta1. H1N1 influenzaA disease-information for healthprofessionals [J].NEnglJMed，2009，360(25)：2666 -2667
[10] CDC,USA.H1N1 Flu (Swine Flu)[EB/OL].(2009-07- 24).http：//edc.gov/h1n1Ⅱu/index.htm
[11] Centers for Disease Control and Prevention (CDC).Serumcross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine [J]. MMWR MorbMortal WklyRep：2009，58(19)：521-524
, 百拇医药
[12] Enserink M Kaiser J.Swine flu outbreak.Devilishdilemmassurround pandemic flu vaccine [J].Science，2009，324(5928)：702—705
[13] VellozziC，Burwen D R，DobardzicA，eta1.Safetyof trivalent inactivatedinfluenza vaccinesin adults：background for pandemic influenza vaccine safety monitoring [J] Vaccine，2009，27(15)：2114- 2120
[14] Response after One Dose of a Monovalent Influenza A(H1N1) Vaccine—Preliminary Report,N Eng J Med 2009;361:2407-17
, 百拇医药
[15] Trial of Influenza A(H1N1)2009 Monovalent MF59-Adjuvanted Vaccine- Preliminary Report,N Eng J Med 2009;361:2303-12
[16] Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus,N Eng J Med 2009;361:2602-07
[17] Feng-Cai Zhu.A Novel Influenza A (H1N1) Vaccine in Various Age Groups.NEnglJ Med2009; 361:2414-23
[18] Tristan W.Clark,M.R.C.P.,Manish Pareek,M.R.C.P.,Katja Hoschler,Ph.D.,etal.Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine,N Engl J Med 2009;361:2424-35
, 百拇医药
[19] Centers for DiseaseControl and Prevention (CDC).Update：drug susceptibility of swine-origininfuenza A(H1N1) viruses，April 2009 [J].M MWR Morb Mortal Wkly Rep，2009，5 8(16)：433—435
[20] Neumann G，Noda T，Kawaoka Y.Emergence and pandemic potential of swine-origin H1N1 influenza virus [J]. ature，2009，459(7249)：931-939
共2页, 百拇医药(龙胜泽 秦志强)